Published financial brief
5122B
NORTHWEST HEALTHCARE PPTYS
- As of
- 2024-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
3 data notes
- Input provenance requires review.
- One or more values are unavailable.
- A displayed ratio exceeds the warning bound.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20202020-12-31 | FY 20212021-12-31 | FY 20222022-12-31 | FY 20232023-12-31 | FY 20242024-12-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 439.5 | 513.6 | 493.8 | 522.7 | 465.7 |
| Cost of goods soldUSD millions | 150.8 | 171.3 | 178.7 | 228.7 | 184.2 |
| Selling, general and administrative expenseUSD millions | —missing | —missing | —missing | —missing | —missing |
| Depreciation and amortizationUSD millions | 1.6 | 1.4 | 1.4 | 1.3 | 3.7 |
| Net incomeUSD millions | 314.4 | 383.5 | 64.3 | -347.7 | -299.8 |
| Operating profit (EBIT)USD millions | 287.1 | 340.9 | 313.7 | 292.8 | 277.8 |
| Income taxesUSD millions | 14.8 | 124.2 | 79.3 | -18.3 | -49.5 |
| Short-term debtUSD millions | 906.4 | 1,073.4 | 1,620.4 | 337.1 | 320.9 |
| Long-term debtUSD millions | 1,881.9 | 1,870.8 | 2,060.8 | 3,581.4 | 2,693.2 |
| Cash and equivalentsUSD millions | 144.2 | 62.7 | 88 | 72.1 | 53 |
| ReceivablesUSD millions | 31.5 | 73.5 | 38.8 | 46 | 55.1 |
| InventoryUSD millions | 0 | 0 | 0 | 0 | 0 |
| PayablesUSD millions | 92.3 | 90 | 133.3 | 128.8 | 105.1 |
| Net property, plant and equipmentUSD millions | 2.7 | 2.5 | 4.7 | 4.8 | 3.4 |
| Capital expenditureUSD millions | 0.2 | 0.5 | 0.6 | 0.1 | 0.9 |
| Operating cash flowUSD millions | 188.8 | 125 | 224.2 | 104.8 | 86.6 |
| Prepaid expensesUSD millions | —missing | —missing | 3.7 | 7.7 | —missing |
| AccrualsUSD millions | —missing | —missing | —missing | —missing | —missing |
| EBITDAUSD millions | 288.7 | 342.3 | 315.1 | 294 | 281.5 |
| Working capitalUSD millions | —missing | —missing | —missing | —missing | —missing |
| Working capital requirementUSD millions | -60.9 | -16.5 | -94.5 | -82.8 | -50 |
| Total debtUSD millions | 2,788.2 | 2,944.2 | 3,681.1 | 3,918.5 | 3,014 |
| Free cash flowUSD millions | 188.5 | 124.5 | 223.6 | 104.7 | 85.8 |
| Unlevered free cash flowUSD millions | 301.2 | 239.9 | 271.1 | 271.5 | 210.6 |
| Returns and ratios | |||||
| ROICratio | 381.6% | 242.9% | 559.5% | 656.5% | 318.9% |
| Pre-tax ROICratio | 396.4% | 292.2% | 912.7% | 681.5% | 368.3% |
| Effective tax rateratio | 3.7% | 16.9% | 38.7% | 3.7% | 13.4% |
| Revenue growthratio | 19.8% | 16.9% | -3.8% | 5.8% | -10.9% |
| EBIT / Revenueratio | 65.3% | 66.4% | 63.5% | 56% | 59.7% |
| Revenue / Invested capitalmultiple | 6.07× | 4.4× | 14.37× | 12.17× | 6.17× |
| Cogs Over Revenuesratio | 34.3% | 33.4% | 36.2% | 43.7% | 39.6% |
| Sga Over Revenuesratio | —missing | —missing | —missing | —missing | —missing |
| Da Over Revenuesratio | 0.4% | 0.3% | 0.3% | 0.2% | 0.8% |
| Nfa Over Revenuesratio | 0.6% | 0.5% | 1% | 0.9% | 0.7% |
| Wcr Over Revenuesratio | -13.9% | -3.2% | -19.1% | -15.8% | -10.7% |
| Debt Over Ebitdamultiple | 9.66× | 8.6× | 11.68× | 13.33× | 10.71× |
| St Debt Over Cashmultiple | 6.29× | 17.11× | 18.41× | 4.68× | 6.06× |
| Interest Over Ebitdamultiple | 0.4× | 0.35× | 0.61× | 0.94× | 0.87× |
| Interest Over Nocf Nicfmultiple | 0.61× | 0.97× | 0.86× | 2.64× | 2.84× |
| Nsf Over Wcrmultiple | -12.52× | -61.23× | -16.21× | -3.2× | -5.36× |
Ask this snapshot
Research assistant
5122B · annualSnapshot e10a07d0
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000